"It’s a privilege to join Compass at such a pivotal time, bringing my expertise to an organisation at the forefront of mental health innovation. I look forward to helping the company continue its journey and execute its strategy, as I share Compass’s passion and determination to improve mental health care for the millions of people who urgently need better options."

Teri Loxam

Chief Financial Officer

Experienced biotech executive and finance leader

Teri has extensive strategic experience working for publicly traded companies, in the pharmaceutical and biotechnology sectors, and beyond. She joined Compass from Gameto, where she was CFO and played a pivotal role in negotiating multiple licensing agreements and helping to develop the regulatory and commercial strategy for their lead product. Teri previously served as CFO and Chief Operating Officer of Kira Pharmaceuticals, where she advanced their lead asset into Phase 2 and grew the company’s pipeline. As CFO of SQZ Biotech, Teri led the company to a successful IPO and raised over $200 million in her first 18 months in her role. Earlier in her career, she held senior leadership positions in investor relations and global communications at Merck and Co. and Bristol-Myers Squibb, and served as Vice President of Investor Relations at IMAX, an entertainment technology company.  Teri also serves as a member of the boards of directors and audit chair of Vaxcyte, Inc. and Cardiol Therapeutics.

"It’s a privilege to join Compass at such a pivotal time, bringing my expertise to an organisation at the forefront of mental health innovation. I look forward to helping the company continue its journey and execute its strategy, as I share Compass’s passion and determination to improve mental health care for the millions of people who urgently need better options."
Back to Our Team